199 related articles for article (PubMed ID: 376728)
1. Production and characterization of DR xenoantisera: use for detection of serum DR antigens.
Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
J Immunol; 1979 May; 122(5):1967-71. PubMed ID: 376728
[TBL] [Abstract][Full Text] [Related]
2. A simple method for production of specific xenoantisera to human histocompatibility (HLA-A,-B,-C) antigens.
Wilson BS; Pellegrino MA; Reisfeld RA; Ferrone S
Transplant Proc; 1978 Dec; 10(4):741-3. PubMed ID: 366831
[No Abstract] [Full Text] [Related]
3. Procedure for the selection of HLA xenoantisera for immunochemical characterization of HLA antigens.
Allison JP; Ferrone S; Pellegrino MA; Reisfeld RA
Transplant Proc; 1977 Mar; 9(1):601-4. PubMed ID: 194373
[No Abstract] [Full Text] [Related]
4. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
Imai K; Ferrone S
Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of DR antigens isolated from body fluids.
Indiveri F; Wilson BS; Natali PG; Pellegrino MA; Ferrone S
Transplant Proc; 1980 Mar; 12(1):121-4. PubMed ID: 7368284
[No Abstract] [Full Text] [Related]
7. A reevaluation of the putative association between the Fc gamma receptor and histocompatibility antigens on human mononuclear leukocytes.
Pulleyblank BM; Falk JA; Letarte M; Dorrington KJ; Falk RE
J Immunol; 1982 Jun; 128(6):2810-5. PubMed ID: 6210736
[TBL] [Abstract][Full Text] [Related]
8. Serologic and immunochemical characterization of HLA-A9 xenoantisera.
Allison JP; Belvedere M; Reisfeld RA; Pellegrino MA; Ferrone S
J Immunol; 1978 Aug; 121(2):579-85. PubMed ID: 681750
[TBL] [Abstract][Full Text] [Related]
9. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
[TBL] [Abstract][Full Text] [Related]
10. Absence of DR antigens on human T lymphoid cells: serologic and immunochemical studies with xenoantisera.
Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
Transplant Proc; 1979 Mar; 11(1):712-4. PubMed ID: 377706
[No Abstract] [Full Text] [Related]
11. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
Lloyd KO; Ng J; Dippold WG
J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer).
Schlesinger M; Rabinowitz R; Kertes T; Ravid Z; Goldblum N
Thymus; 1981 Feb; 2(4-5):235-43. PubMed ID: 7015584
[TBL] [Abstract][Full Text] [Related]
14. Classification of human leukemia by membrane antigen analysis with xenoantisera.
Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
[TBL] [Abstract][Full Text] [Related]
15. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
[TBL] [Abstract][Full Text] [Related]
17. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
19. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
